比较3组相关导联再灌注心律失常发生率、ST段回落率、校正心肌梗死溶栓治疗（TIMI）帧数（CTFC）、肌酸激酶同工酶（CK-MB）峰值、左室射血分数（LVEF）的变化，并随访不良事件的发生情况。
基于276个网页-相关网页
结果:替罗非班组于术前应用盐酸替罗非班使PCI前梗死相关血管心肌梗死溶栓治疗(thrombolysis in myocardial infarction,TIMI)血流分级提高,替罗非班组达1级、2级血流者比例分别高于对照组(均P<0·01),对照组完全闭塞比率明...
基于8个网页-相关网页
心肌梗死溶栓治疗试验 thrombolysis in myocardial infarction trial ; TIMI
校正心肌梗死溶栓治疗 thrombolysis in myocardial infarction ; TIMI
使用心肌梗死溶栓治疗 Thrombolysis in Myocardial Infarction ; TIMI
而心肌梗死溶栓治疗 trombolysis in myocardial infarction
目的：评价国产尿激酶在急性心肌梗死溶栓治疗中的有效性和安全性。
Objective: To study the efficacy and safety with thrombolysis of urokinase produced in China on acute myocardial infarction.
目的探讨在急诊科静脉溶栓治疗急性心肌梗死(ami)患者的临床效果及安全性。
Objective To study clinical efficacy of thrombolytic therapy in Emergency Department for acute myocardial infarction (AMI).
应用门电路平衡法心血池显像，对急性心肌梗死经尿激酶静脉溶栓治疗患者测定其左心室功能。
We evaluated the left ventricular function of acute myocardial infarction patients given thrombolytic therapy with urokinase by multiple gated equilibrium cardiac blood pool imaging.
应用推荐